Global Oncology Marketing Director: Forecasting & Launch

MSD Malaysia; Rahway (NJ); Hybrid; USD 191,000 - 300,000; Full time

Benefits offered by this job

Annual bonus

Long-term incentive

Comprehensive benefits

Job summary

Merck & Co., Inc. in Rahway, NJ, is seeking a Global Oncology Marketing Director to lead sac-TMT forecasting, overlay and profit plan across indications, and coordinate with finance, DDA, and regional teams to ensure launch success.

This senior role requires strong leadership, strategic thinking, and deep knowledge of commercial oncology strategy, with responsibility for long-term registrational trials and opportunities to address unmet patient needs.

Qualifications

• Bachelor's degree; minimum 7+ years healthcare business experience in marketing, forecasting, sales, or related fields.
• Experience leading strategy development and implementation in pharmaceutical/biotech settings.
• Strong collaboration, leadership, communication and presentation skills.

Responsibilities

• Lead sac-TMT forecasting across indications for twice-yearly forecasts, Overlay and Profit Plan.
• Coordinate with forecasting, finance and DDA teams and align with regional counterparts.
• Lead trimester business reviews and standardize post-launch performance reporting.
• Evaluate new opportunities for sac-TMT with input from asset and tumor marketing teams.
• Serve as new product leader for long-term registrational trials and signal-finding studies.

Skills

Business Agility

Forecasting

Strategic Thinking

Leadership

Oncology Marketing

Market Assessments

Product Launch

Strategic Planning

Commercial Acumen

Planning Ability

Education

Bachelor's Degree

MBA

Job description

Merck & Co., Inc. in Rahway, NJ, is seeking a Global Oncology Marketing Director to lead sac-TMT forecasting, overlay and profit plan across indications, and coordinate with finance, DDA, and regional teams to ensure launch success.

This senior role requires strong leadership, strategic thinking, and deep knowledge of commercial oncology strategy, with responsibility for long-term registrational trials and opportunities to address unmet patient needs.